Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Revlimid
Pharma
After $1.5B cost-cutting plan, BMS will cut an additional $2B
The new plan will slash $2 billion in costs by the end of 2027 and comes on top of a $1.5 billion initiative that the company unveiled in April.
Kevin Dunleavy
Feb 6, 2025 8:33am
CEO says BMS can handle impact of IRA price negotiation
Jul 26, 2024 11:36am
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Dec 12, 2023 12:00pm
Sanofi targets first-line myeloma as Sarclisa delivers trial win
Dec 7, 2023 11:26am
BMS aims for staggering 25 label expansions in the coming years
Sep 15, 2023 12:04pm
BMS again cuts staff after disappointing 2Q earnings
Aug 11, 2023 2:41pm
